Skip to main content
Log in

A Clinical Decision Rule to Aid Ordering of Serum and Urine Protein Electrophoresis for Case-Finding of Paraproteins in Hospitalized Inpatients

  • Original Article
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

Abstract

Objective

To develop a simple clinical decision rule that could increase the yield of serum and urine protein electrophoresis (SPE/UPE) without loss of sensitivity.

Design

A cross-sectional study of inpatients with a SPE/UPE performed over a 5-year period (2001–2006) with complete data on electrolytes, globulins, full blood count, creatinine, age, and gender.

Setting

A tertiary-care general teaching hospital serving the Hunter Valley in New South Wales, with a referral population of over 1 million.

Participants

A total of 14,374 adult patients admitted between January 2001–November 2006.

Main outcome measures

Paraprotein on serum and/or urine protein electrophoresis (SPE/UPE).

Results

Five points were assigned for globulin >41 g/l, 3 points for age ≥60, 2 points for each of hemoglobin <121 and male gender, and 1 point for estimated glomerular filtration rate (eGFR) <60. Total scores of 0–5, 6–10, and ≥11 corresponded to positive likelihood ratios of an abnormal SPE/UPE of 1, 2.5, and 6.6, respectively. The predictive ability of this model was strong, with an area under the curve of ∼0.8. Results in the validation set were almost identical.

Conclusion

A clinical decision rule using simple clinical variables has the potential to improve the yield of SPE/UPE. This rule however needs to be verified prospectively.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

Similar content being viewed by others

References

  1. Beetham R, Howie N, Soutar R. Can opportunistic case-finding of paraproteins be clinically justified? Ann Clin Biochem. 2005;42:245–53.

    Article  PubMed  Google Scholar 

  2. Hughes M, Davidson DF, McColl M. Outcomes of discretionary laboratory testing of serum protein electrophoresis. Ann Clin Biochem. 2006;43:372–4.

    Article  PubMed  CAS  Google Scholar 

  3. Malacrida V, De Francesco D, Banfi G, Porta FA, Riches PG. Laboratory investigation of monoclonal gammopathy during 10 years of screening in a general hospital. J Clin Pathol. 1987;40:793–7.

    Article  PubMed  CAS  Google Scholar 

  4. McKenna P, Dewar M, Tiplady C, Jones K. Should the laboratory initiate requests for myeloma screening? Clin Chim Acta. 2005;355:S287.

    Google Scholar 

  5. Gabow PA. Disorders associated with an altered anion gap. Kidney Int. 1985;27:472–83.

    Article  PubMed  CAS  Google Scholar 

  6. Murray T, Long W, Narins RG. Multiple myeloma and the anion gap. N Engl J Med. 1975;292:574–5.

    PubMed  CAS  Google Scholar 

  7. Flanagan NG, Ridway JC, Irving AG. The anion gap as a screening procedure for occult myeloma in the elderly. Journal of the Royal Society of Medicine. 1988;81:27–8.

    PubMed  CAS  Google Scholar 

  8. De Troyer A, Stolarczyk A, De Beyl DZ, Stryckmans P. Value of anion-gap determination in multiple myeloma. N Engl J Med. 1977;29:858–60.

    Google Scholar 

  9. Cambareri J. Probability of myeloma in patients with low anion gap. Lancet. 1982;i:333–4.

    Article  Google Scholar 

  10. Goldstein RJ, Lichtenstein NS, Souder D. The myth of the low anion gap. JAMA. 1980;243:1737–8.

    Article  PubMed  CAS  Google Scholar 

  11. Keshgegian AA. The low anion gap [letter]. JAMA. 1980;244:2047–8.

    Article  Google Scholar 

  12. Mitnick PD. The low anion gap [letter]. JAMA. 1980;244:2047.

    Article  Google Scholar 

  13. Narins RG, Emmett M. The low anion gap [letter]. JAMA. 1980;244:2047.

    Article  Google Scholar 

  14. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–266, Feb.

    Google Scholar 

  15. Nordin BEC, Need AG, Hartley TF, Philcox JC, Thomas DW. Improved method for calculating fractions in plasma: Reference values and effect of menopause. Clin Chem. 1989;35:14–7.

    PubMed  CAS  Google Scholar 

  16. Data management. Stata Statistical Software: Release 10. College Station; TX: StataCorp LP; 2007.

  17. Harrell FE Jr., Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Statistics in medicine. 1996 Feb 28;154361–87.

    Article  PubMed  Google Scholar 

  18. Grimes DA, Schulz KF. Refining clinical diagnosis with likelihood ratios. Lancet. 2005;36594691500–5. Apr 23–29.

    Article  PubMed  Google Scholar 

  19. Tracey E, Chen S, Baker D, Bishop J, Jelfs P. Cancer in New South Wales. Incidence and mortality report 2004: Cancer Institute NSW; 2004.

  20. Young B, Gleeson M. Audit of investigation and follow-up of patinets with raised monoclonal proteins. Aust Clin Rev. 1989;8:217–20.

    PubMed  CAS  Google Scholar 

  21. Kyle RA, Therneau TM, Rajkumar SV, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med. 2002;346:564–9.

    Article  PubMed  Google Scholar 

  22. Attia J. Moving beyond sensitivity and specificity: using likelihood ratios to help interpret diagnostic tests. Australian Prescriber. 2003;26:111–13.

    Google Scholar 

  23. Jaeschke R, Guyatt G, Lijmer J. Diagnostic Tests. In: Guyatt G, Rennie D, eds. Users’ Guides to the Medical Literature A Manual for Evidence-Based Clinical Practice: AMA Press; 2002. p. 121–40.

  24. Jaeschke R, Guyatt G, Sackett DL. Users’ guides to the medical literature. III How to use an article about a diagnostic test. A. Are the results of the study valid? JAMA. 1994;271:389–91.

    Article  PubMed  CAS  Google Scholar 

  25. Jaeschke R, Guyatt G, Sackett DL. Users’ guides to the medical literature. III How to use an article about a diagnostic test. B. What are the results and will they help me care for my patient? JAMA. 1994;271:703–7.

    Article  PubMed  CAS  Google Scholar 

  26. Alyanakian M-A, Abbas A, Delarue R, Arnulf B, Aucouturier P. Free immunoglobulin light-chain serum levels in the follow-up of patients with monoclonal gammopathies: correlation with 24-hr urinary light-chain excretion. Am J Hematol. 2004;75:246–8.

    Article  PubMed  Google Scholar 

  27. Bradwell AR, Carr-Smith HD, Mead GP, Harvey TC, Drayson MT. Serum test for assessment of patients with Bence Jones myeloma. Lancet. 2003;361:489–91.

    Article  PubMed  Google Scholar 

Download references

Acknowledgement

The authors declare that there was no conflict of interest, and there was no financial support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John Attia PhD, FRCPC, FRACP.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thakkinstian, A., Tran, H., Reeves, G. et al. A Clinical Decision Rule to Aid Ordering of Serum and Urine Protein Electrophoresis for Case-Finding of Paraproteins in Hospitalized Inpatients. J GEN INTERN MED 23, 1688–1692 (2008). https://doi.org/10.1007/s11606-008-0712-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11606-008-0712-z

KEY WORDS

Navigation